| Mrs Lindsay Tatum Hartman, NP | |
|
121 Medical Dr, Advance, NC 27006-6651 | |
| (336) 998-9060 | |
| (336) 998-9061 |
| Full Name | Mrs Lindsay Tatum Hartman |
|---|---|
| Gender | Female |
| Speciality | Nurse Practitioner |
| Experience | 18 Years |
| Location | 121 Medical Dr, Advance, North Carolina |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1932225687 | NPI | - | NPPES |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Novant Medical Group Inc | 1153234893 | 1996 |
News Archive
A potentially safer, more effective chemotherapy treatment for patients with blood-related cancers, such as leukemia, who need a particular bone marrow transplant procedure is under study at the University of Arizona Health Sciences.
Glenmark Generics Inc. USA, the subsidiary of Glenmark Generics Limited, has been granted final approval for its abbreviated new drug application (ANDA) from the United States Food and Drug Administration for Omeprazole Delayed Release Capsules, their generic version of Prilosec by AstraZeneca.
Scientists have demonstrated for the first time that it is possible to specifically modify gene expression in diseased upper motor neurons, brain cells that break down in ALS.
A new prostate cancer "homing device" could improve detection and allow for the first targeted treatment of the disease. A team of Purdue University researchers has synthesized a molecule that finds and penetrates prostate cancer cells and has created imaging agents and therapeutic drugs that can link to the molecule and be carried with it as cargo.
› Verified 1 days ago
| Entity Name | Novant Medical Group Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1366409492 PECOS PAC ID: 1153234893 Enrollment ID: O20031121000692 |
News Archive
A potentially safer, more effective chemotherapy treatment for patients with blood-related cancers, such as leukemia, who need a particular bone marrow transplant procedure is under study at the University of Arizona Health Sciences.
Glenmark Generics Inc. USA, the subsidiary of Glenmark Generics Limited, has been granted final approval for its abbreviated new drug application (ANDA) from the United States Food and Drug Administration for Omeprazole Delayed Release Capsules, their generic version of Prilosec by AstraZeneca.
Scientists have demonstrated for the first time that it is possible to specifically modify gene expression in diseased upper motor neurons, brain cells that break down in ALS.
A new prostate cancer "homing device" could improve detection and allow for the first targeted treatment of the disease. A team of Purdue University researchers has synthesized a molecule that finds and penetrates prostate cancer cells and has created imaging agents and therapeutic drugs that can link to the molecule and be carried with it as cargo.
› Verified 1 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Mrs Lindsay Tatum Hartman, NP Po Box 751803, Charlotte, NC 28275-1803 Ph: (336) 998-9060 | Mrs Lindsay Tatum Hartman, NP 121 Medical Dr, Advance, NC 27006-6651 Ph: (336) 998-9060 |
News Archive
A potentially safer, more effective chemotherapy treatment for patients with blood-related cancers, such as leukemia, who need a particular bone marrow transplant procedure is under study at the University of Arizona Health Sciences.
Glenmark Generics Inc. USA, the subsidiary of Glenmark Generics Limited, has been granted final approval for its abbreviated new drug application (ANDA) from the United States Food and Drug Administration for Omeprazole Delayed Release Capsules, their generic version of Prilosec by AstraZeneca.
Scientists have demonstrated for the first time that it is possible to specifically modify gene expression in diseased upper motor neurons, brain cells that break down in ALS.
A new prostate cancer "homing device" could improve detection and allow for the first targeted treatment of the disease. A team of Purdue University researchers has synthesized a molecule that finds and penetrates prostate cancer cells and has created imaging agents and therapeutic drugs that can link to the molecule and be carried with it as cargo.
› Verified 1 days ago
Martha Eseh, NP Nurse Practitioner Medicare: Medicare Enrolled Practice Location: 196 Arnold Palmer Dr, Advance, NC 27006 Phone: 804-350-5824 | |
Christian Connor Hall, C.P.N.P Nurse Practitioner Medicare: Not Enrolled in Medicare Practice Location: 114 Kinderton Blvd, Advance, NC 27006 Phone: 336-998-9742 | |
Amanda Marie Seymour, FNP Nurse Practitioner Medicare: Medicare Enrolled Practice Location: 132 Ashley Furniture Way, Advance, NC 27006 Phone: 336-713-8948 Fax: 336-702-9285 | |
Kendra Roten, NP Nurse Practitioner Medicare: Medicare Enrolled Practice Location: 132 Ashley Furniture Way, Advance, NC 27006 Phone: 336-713-8948 | |
Gemekia Coleman Futrell, FNP Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 147 Peachtree Ln, Advance, NC 27006 Phone: 336-716-2011 | |
Casey Kenyon Mahle, CPNP-PC Nurse Practitioner Medicare: Medicare Enrolled Practice Location: 114 Kinderton Blvd, Advance, NC 27006 Phone: 336-998-9742 Fax: 336-998-9410 | |
Amanda Janel Goad, NP Nurse Practitioner Medicare: Not Enrolled in Medicare Practice Location: 157 Yadkin Valley Rd, Advance, NC 27006 Phone: 336-777-6093 |